These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study. Fouquet C, Antoine M, Tisserand P, Favis R, Wislez M, Commo F, Rabbe N, Carette MF, Milleron B, Barany F, Cadranel J, Zalcman G, Soussi T. Clin Cancer Res; 2004 May 15; 10(10):3479-89. PubMed ID: 15161705 [Abstract] [Full Text] [Related]
5. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer. Wu X, Lu XH, Xu T, Qian JM, Zhao P, Guo XZ, Yang XO, Jiang WJ. Chin J Dig Dis; 2006 May 15; 7(3):170-4. PubMed ID: 16808798 [Abstract] [Full Text] [Related]
8. Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China. Keohavong P, Lan Q, Gao WM, Zheng KC, Mady HH, Melhem MF, Mumford JL. Carcinogenesis; 2005 Feb 15; 26(2):303-8. PubMed ID: 15564291 [Abstract] [Full Text] [Related]
12. Detection of K-ras mutations by a microelectronic DNA chip. Lopez-Crapez E, Livache T, Caillat P, Zsoldos D. Methods Mol Med; 2004 Feb 15; 97():337-54. PubMed ID: 15064504 [No Abstract] [Full Text] [Related]
13. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem J, Jassem E, Jakóbkiewicz-Banecka J, Rzyman W, Badzio A, Dziadziuszko R, Kobierska-Gulida G, Szymanowska A, Skrzypski M, Zylicz M. Cancer; 2004 May 01; 100(9):1951-60. PubMed ID: 15112277 [Abstract] [Full Text] [Related]
14. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing. Chong IW, Chang MY, Sheu CC, Wang CY, Hwang JJ, Huang MS, Lin SR. Oncol Rep; 2007 Jul 01; 18(1):17-24. PubMed ID: 17549340 [Abstract] [Full Text] [Related]
19. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Hu Y, McDermott MP, Ahrendt SA. Clin Cancer Res; 2005 Apr 01; 11(7):2502-9. PubMed ID: 15814626 [Abstract] [Full Text] [Related]
20. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Wang Y, Zhang Z, Lubet RA, You M. Oncogene; 2006 Feb 23; 25(8):1277-80. PubMed ID: 16247444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]